Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation

Autores
Marín, Gustavo Horacio; Risso, Paula; Sbattella, Daniela; Haag, Griselda Octavia
Año de publicación
2015
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Objectives: We examined the impact of personalizing antidiabetic agents in treatment adherence and in health outcome of socioeconomic vulnerable patients. Methods: We conducted a randomized controlled trial comparing usual “on demand” drug supply from Primary Health Care (PHC) Centers; with a drug dispensing strategy based on a personalized process. 469 patients with type-2 diabetes (DBT) were assigned to either control (CG) or intervention group (IG) assuring a balance in main risk factors. Primary trial endpoint was treatment compliance; however aspects like health events associated to DBT were also evaluated. Results: Adherence to oral agents in CG was 15.57% and 92.09% in IG (p <0.001). Dose omissions represented the most prevalent form of non-adherence. Weight loss was greater in the intervention group than in the control group throughout the study (5.4% in overall weight reduction at study end). Hospital admissions (16.80% vs 10.23% - p <0.01) and coronary heart events (7.37% vs. 3.72% p 0.03) were higher for CG when compared with IG. Conclusions: Diabetes faces the challenge of lifelong treatment. This task is difficult for every patient but is especially hard in social vulnerable situation. Our initiative demonstrate that for the poor and uninsured population, personalizing drug dispensing showed a high level of treatment compliance, and benefits in terms of health consequences associated to diabetes. This experience might be useful for primary care health teams in order to better control social underserved patients, and also for reducing the economical impact for health system caused by complications due to untreated diabetes
Facultad de Ciencias Médicas
Materia
Salud
Ciencias Médicas
diabetes
Personalized
Treatment
Adherence
Primary health care
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by/4.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/127605

id SEDICI_ec1b0641b1f521d050ecb9ea4cb3f5d3
oai_identifier_str oai:sedici.unlp.edu.ar:10915/127605
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situationMarín, Gustavo HoracioRisso, PaulaSbattella, DanielaHaag, Griselda OctaviaSaludCiencias MédicasdiabetesPersonalizedTreatmentAdherencePrimary health careObjectives: We examined the impact of personalizing antidiabetic agents in treatment adherence and in health outcome of socioeconomic vulnerable patients. Methods: We conducted a randomized controlled trial comparing usual “on demand” drug supply from Primary Health Care (PHC) Centers; with a drug dispensing strategy based on a personalized process. 469 patients with type-2 diabetes (DBT) were assigned to either control (CG) or intervention group (IG) assuring a balance in main risk factors. Primary trial endpoint was treatment compliance; however aspects like health events associated to DBT were also evaluated. Results: Adherence to oral agents in CG was 15.57% and 92.09% in IG (p &lt;0.001). Dose omissions represented the most prevalent form of non-adherence. Weight loss was greater in the intervention group than in the control group throughout the study (5.4% in overall weight reduction at study end). Hospital admissions (16.80% vs 10.23% - p &lt;0.01) and coronary heart events (7.37% vs. 3.72% p 0.03) were higher for CG when compared with IG. Conclusions: Diabetes faces the challenge of lifelong treatment. This task is difficult for every patient but is especially hard in social vulnerable situation. Our initiative demonstrate that for the poor and uninsured population, personalizing drug dispensing showed a high level of treatment compliance, and benefits in terms of health consequences associated to diabetes. This experience might be useful for primary care health teams in order to better control social underserved patients, and also for reducing the economical impact for health system caused by complications due to untreated diabetesFacultad de Ciencias Médicas2015info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf93-96http://sedici.unlp.edu.ar/handle/10915/127605enginfo:eu-repo/semantics/altIdentifier/issn/1479-1064info:eu-repo/semantics/altIdentifier/issn/1479-1072info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0/Creative Commons Attribution 4.0 International (CC BY 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-29T11:30:52Zoai:sedici.unlp.edu.ar:10915/127605Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-29 11:30:53.002SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation
title Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation
spellingShingle Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation
Marín, Gustavo Horacio
Salud
Ciencias Médicas
diabetes
Personalized
Treatment
Adherence
Primary health care
title_short Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation
title_full Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation
title_fullStr Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation
title_full_unstemmed Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation
title_sort Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation
dc.creator.none.fl_str_mv Marín, Gustavo Horacio
Risso, Paula
Sbattella, Daniela
Haag, Griselda Octavia
author Marín, Gustavo Horacio
author_facet Marín, Gustavo Horacio
Risso, Paula
Sbattella, Daniela
Haag, Griselda Octavia
author_role author
author2 Risso, Paula
Sbattella, Daniela
Haag, Griselda Octavia
author2_role author
author
author
dc.subject.none.fl_str_mv Salud
Ciencias Médicas
diabetes
Personalized
Treatment
Adherence
Primary health care
topic Salud
Ciencias Médicas
diabetes
Personalized
Treatment
Adherence
Primary health care
dc.description.none.fl_txt_mv Objectives: We examined the impact of personalizing antidiabetic agents in treatment adherence and in health outcome of socioeconomic vulnerable patients. Methods: We conducted a randomized controlled trial comparing usual “on demand” drug supply from Primary Health Care (PHC) Centers; with a drug dispensing strategy based on a personalized process. 469 patients with type-2 diabetes (DBT) were assigned to either control (CG) or intervention group (IG) assuring a balance in main risk factors. Primary trial endpoint was treatment compliance; however aspects like health events associated to DBT were also evaluated. Results: Adherence to oral agents in CG was 15.57% and 92.09% in IG (p &lt;0.001). Dose omissions represented the most prevalent form of non-adherence. Weight loss was greater in the intervention group than in the control group throughout the study (5.4% in overall weight reduction at study end). Hospital admissions (16.80% vs 10.23% - p &lt;0.01) and coronary heart events (7.37% vs. 3.72% p 0.03) were higher for CG when compared with IG. Conclusions: Diabetes faces the challenge of lifelong treatment. This task is difficult for every patient but is especially hard in social vulnerable situation. Our initiative demonstrate that for the poor and uninsured population, personalizing drug dispensing showed a high level of treatment compliance, and benefits in terms of health consequences associated to diabetes. This experience might be useful for primary care health teams in order to better control social underserved patients, and also for reducing the economical impact for health system caused by complications due to untreated diabetes
Facultad de Ciencias Médicas
description Objectives: We examined the impact of personalizing antidiabetic agents in treatment adherence and in health outcome of socioeconomic vulnerable patients. Methods: We conducted a randomized controlled trial comparing usual “on demand” drug supply from Primary Health Care (PHC) Centers; with a drug dispensing strategy based on a personalized process. 469 patients with type-2 diabetes (DBT) were assigned to either control (CG) or intervention group (IG) assuring a balance in main risk factors. Primary trial endpoint was treatment compliance; however aspects like health events associated to DBT were also evaluated. Results: Adherence to oral agents in CG was 15.57% and 92.09% in IG (p &lt;0.001). Dose omissions represented the most prevalent form of non-adherence. Weight loss was greater in the intervention group than in the control group throughout the study (5.4% in overall weight reduction at study end). Hospital admissions (16.80% vs 10.23% - p &lt;0.01) and coronary heart events (7.37% vs. 3.72% p 0.03) were higher for CG when compared with IG. Conclusions: Diabetes faces the challenge of lifelong treatment. This task is difficult for every patient but is especially hard in social vulnerable situation. Our initiative demonstrate that for the poor and uninsured population, personalizing drug dispensing showed a high level of treatment compliance, and benefits in terms of health consequences associated to diabetes. This experience might be useful for primary care health teams in order to better control social underserved patients, and also for reducing the economical impact for health system caused by complications due to untreated diabetes
publishDate 2015
dc.date.none.fl_str_mv 2015
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Articulo
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://sedici.unlp.edu.ar/handle/10915/127605
url http://sedici.unlp.edu.ar/handle/10915/127605
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/issn/1479-1064
info:eu-repo/semantics/altIdentifier/issn/1479-1072
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by/4.0/
Creative Commons Attribution 4.0 International (CC BY 4.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0/
Creative Commons Attribution 4.0 International (CC BY 4.0)
dc.format.none.fl_str_mv application/pdf
93-96
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1844616188481503232
score 13.070432